认知行为疗法结合中药治疗焦虑症的临床观察
|
摘要
目的研究认知行为疗法结合中药治疗焦虑症的临床效果。方法选取我院2016年7月至2017年7月收治的焦虑症患者126例,随机为两组各63例。对照组实施认知行为疗法,研究组在对照组基础上采用中药治疗。比较两组患者的临床疗效与HAMD评分。结果治疗1周、 3周、 6周后,研究组的HAMD评分均显著低于对照组(P <0.05)。研究组的治疗总有效率为92.06%,高于对照组的77.78%(P <0.05)。研究组的不良反应发生率为7.94%,低于对照组的20.63%(P <0.05)。结论认知行为疗法结合中药治疗焦虑症患者,临床疗效显著,患者焦虑症状明显出现好转,用药期间较为安全,值得临床应用。
Objective To study the clinical effect of cognitive behavioral therapy combined with traditional Chinese medicine in the treatment of anxiety disorder. Methods 126 cases of patients with anxiety disorder admitted to our hospital from July 2016 to July 2017 were selected and randomly divided into two groups, with 63 cases in each group. The control group received cognitive behavioral therapy, while the study group was treated with traditional Chinese medicine on the basis of the control group. The clinical efficacy and HAMD scores of the two groups were compared. Results 1 week, 3 weeks and 6 weeks after treatment, the HAMD scores of the study group were significantly lower than those of the control group(P <0.05). The total effective rate of treatment of the study group was 92.06%, higher than77.78% of the control group(P <0.05). The incidence of adverse reactions of the study group were 7.94%, lower than 20.63% of the control group(P <0.05). Conclusions Cognitive behavioral therapy combined with traditional Chinese medicine in the treatment of patients with anxiety disorder has significant clinical curative effect, and significantly improves patients ' anxiety symptoms, which is safer during the medication and is worthy of clincal application.
Objective To study the clinical effect of cognitive behavioral therapy combined with traditional Chinese medicine in the treatment of anxiety disorder. Methods 126 cases of patients with anxiety disorder admitted to our hospital from July 2016 to July 2017 were selected and randomly divided into two groups, with 63 cases in each group. The control group received cognitive behavioral therapy, while the study group was treated with traditional Chinese medicine on the basis of the control group. The clinical efficacy and HAMD scores of the two groups were compared. Results 1 week, 3 weeks and 6 weeks after treatment, the HAMD scores of the study group were significantly lower than those of the control group(P <0.05). The total effective rate of treatment of the study group was 92.06%, higher than77.78% of the control group(P <0.05). The incidence of adverse reactions of the study group were 7.94%, lower than 20.63% of the control group(P <0.05). Conclusions Cognitive behavioral therapy combined with traditional Chinese medicine in the treatment of patients with anxiety disorder has significant clinical curative effect, and significantly improves patients ' anxiety symptoms, which is safer during the medication and is worthy of clincal application.
引文
[1]郑卫峰,赵洛沙,魏经汉,等.艾司西泰普兰联合坦度螺酮对老年女性冠心病合并焦虑抑郁障碍共病患者的疗效[J].中国动脉硬化杂志, 2013, 21(4):345-348.
[2]王飞雪.认知行为疗法结合药物治疗对焦虑症患者社会功能、生活满意度及生活质量的影响[J].中国实用医药, 2016, 11(35):137-138.
[3]赵辉,张小林,齐献忠,等.西酞普兰治疗首发抑郁症老年患者效果及对血清中脑源性神经营养因子和神经肽Y的影响[J].中国老年学杂志, 2017, 37(14):3566-3568.
[4]陈淑燕,谢稚鹃,黄薛冰,等.集体认知行为治疗对广泛性焦虑障碍疗效的随机对照研究[J].中国心理卫生杂志, 2017, 31(3):177-182.
[5]袁天懿,秦玲,唐建良,等.前庭康复训练联合认知行为疗法治疗慢性主观性头晕伴发焦虑的疗效观察[J].中华物理医学与康复杂志, 2016, 38(12):938-941.
[6]张博元,丁雪凡,卢卫红,等.团体认知行为治疗对轻度抑郁症患者生活质量及社会功能的作用[J].上海精神医学, 2016, 28(1):18-27.
[7]汪天宇,李英辉,李磊,等.艾司西酞普兰治疗中国抑郁症患者有效性和安全性的Meta分析[J].中国临床药理学与治疗学, 2015, 20(9):1020-1025.
[8]宁征远,谢姗姗,李健,等.阿戈美拉汀联合坦度螺酮对老年抑郁症患者血清NE、 5-HT水平的影响[J].东南国防医药, 2017, 19(3):251-253.
[9]杜宗汉,袁溢苒,罗君.坦度螺酮联合莫沙必利和雷贝拉唑对反流性食管炎患者氧自由基和炎症因子水平的影响[J].中国综合临床, 2017, 33(11):1010-1013.
[2]王飞雪.认知行为疗法结合药物治疗对焦虑症患者社会功能、生活满意度及生活质量的影响[J].中国实用医药, 2016, 11(35):137-138.
[3]赵辉,张小林,齐献忠,等.西酞普兰治疗首发抑郁症老年患者效果及对血清中脑源性神经营养因子和神经肽Y的影响[J].中国老年学杂志, 2017, 37(14):3566-3568.
[4]陈淑燕,谢稚鹃,黄薛冰,等.集体认知行为治疗对广泛性焦虑障碍疗效的随机对照研究[J].中国心理卫生杂志, 2017, 31(3):177-182.
[5]袁天懿,秦玲,唐建良,等.前庭康复训练联合认知行为疗法治疗慢性主观性头晕伴发焦虑的疗效观察[J].中华物理医学与康复杂志, 2016, 38(12):938-941.
[6]张博元,丁雪凡,卢卫红,等.团体认知行为治疗对轻度抑郁症患者生活质量及社会功能的作用[J].上海精神医学, 2016, 28(1):18-27.
[7]汪天宇,李英辉,李磊,等.艾司西酞普兰治疗中国抑郁症患者有效性和安全性的Meta分析[J].中国临床药理学与治疗学, 2015, 20(9):1020-1025.
[8]宁征远,谢姗姗,李健,等.阿戈美拉汀联合坦度螺酮对老年抑郁症患者血清NE、 5-HT水平的影响[J].东南国防医药, 2017, 19(3):251-253.
[9]杜宗汉,袁溢苒,罗君.坦度螺酮联合莫沙必利和雷贝拉唑对反流性食管炎患者氧自由基和炎症因子水平的影响[J].中国综合临床, 2017, 33(11):1010-1013.